Enhanced Humans

A step toward a potential anti-aging drug

  • These findings raise the possibility that “mTOR inhibitors”* (like rapamycin and RAD001) may have beneficial effects on aging and aging-related conditions in humans.
  • Since it would take decades to test the effect of a drug on life span in humans, the researchers at Novartis Institutes for BioMedical Research and affiliates used a proxy: the decline in immune function in seniors’ (age 65 and older) during aging, as assessed by their response to a flu vaccine.
  • lthough some scientists are reportedly already self-medicating, “the toxicity of RAD001 at doses used in oncology or organ transplantation results in adverse effects such as stomatitis, diarrhea, nausea, cytopenias, hyperlipidemia, and hyperglycemia.”

Keep up. Subscribe to our daily newsletter.

I understand and agree that registration on or use of this site constitutes agreement to its User Agreement and Privacy Policy
Next Article
////////////